Stockscreener 앱 받기
7.425
3.76%
-0.295
전일 마감가:
$7.72
열려 있는:
$7.502
하루 거래량:
1.85M
Relative Volume:
0.71
시가총액:
$672.25M
수익:
$161.10M
순이익/손실:
$-308.60M
주가수익비율:
-1.5899
EPS:
-4.67
순현금흐름:
$-259.90M
1주 성능:
-19.33%
1개월 성능:
+13.26%
6개월 성능:
-72.38%
1년 성능:
-77.36%
1일 변동 폭
$7.33
$7.91
1주일 범위
$6.23
$9.68
52주 변동 폭
$5.935
$37.38
Arvinas Inc Stock (ARVN) Company Profile
명칭
Arvinas Inc
전화
203-535-1456
주소
395 WINCHESTER AVE, NEW HAVEN, CT
ARVN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARVN
Arvinas Inc
|
7.425 | 672.25M | 161.10M | -308.60M | -259.90M | -4.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.49 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.00 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.39 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
269.33 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.48 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Arvinas Inc Stock (ARVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-03-12 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2025-03-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-12-10 | 개시 | BTIG Research | Buy |
| 2024-11-18 | 개시 | Stephens | Overweight |
| 2024-02-28 | 재확인 | Oppenheimer | Outperform |
| 2024-02-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-02-01 | 개시 | Goldman | Buy |
| 2023-12-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-12-06 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-11-20 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2023-10-23 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2023-06-26 | 재개 | Oppenheimer | Outperform |
| 2023-01-12 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-01-03 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-09-09 | 개시 | Barclays | Overweight |
| 2022-06-21 | 개시 | Jefferies | Hold |
| 2022-05-09 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2022-04-28 | 개시 | Credit Suisse | Outperform |
| 2022-04-06 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-02-11 | 재개 | BMO Capital Markets | Outperform |
| 2022-02-10 | 개시 | Wells Fargo | Overweight |
| 2022-01-19 | 개시 | Goldman | Buy |
| 2021-12-07 | 개시 | Cowen | Outperform |
| 2021-10-14 | 개시 | SVB Leerink | Outperform |
| 2021-09-30 | 개시 | Stifel | Buy |
| 2021-09-09 | 개시 | BofA Securities | Buy |
| 2021-05-21 | 개시 | UBS | Buy |
| 2021-04-21 | 개시 | Truist | Buy |
| 2021-03-31 | 개시 | BMO Capital Markets | Outperform |
| 2020-12-14 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-06-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-05-12 | 개시 | Oppenheimer | Perform |
| 2019-12-19 | 개시 | H.C. Wainwright | Buy |
| 2019-11-25 | 개시 | Guggenheim | Buy |
| 2019-10-24 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-09-25 | 개시 | Wedbush | Outperform |
| 2019-09-12 | 개시 | BMO Capital Markets | Outperform |
| 2019-08-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-06-05 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-04-12 | 개시 | Evercore ISI | Outperform |
| 2018-10-22 | 개시 | Citigroup | Buy |
| 2018-10-22 | 개시 | Goldman | Neutral |
| 2018-10-22 | 개시 | Piper Jaffray | Overweight |
모두보기
Arvinas Inc 주식(ARVN)의 최신 뉴스
Arvinas (ARVN) Sees Analyst Downgrade and Significant Price Target Cut | ARVN Stock News - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, ... - Bluefield Daily Telegraph
Arvinas, Inc. (NASDAQ:ARVN) Short Interest Up 21.0% in April - MarketBeat
ARVN: BMO Capital Maintains Rating While Lowering Price Target | ARVN Stock News - GuruFocus
Arvinas (NASDAQ:ARVN) Posts Quarterly Earnings Results, Beats Estimates By $2.07 EPS - MarketBeat
Arvinas, Inc. (NASDAQ:ARVN) Shares Bought by ArrowMark Colorado Holdings LLC - MarketBeat
Arvinas (ARVN) Target Price Lowered by Citi Amid Pipeline Developments | ARVN Stock News - GuruFocus
Citi cuts Arvinas stock price target to $9.50, keeps neutral rating - Investing.com India
Truist Downgrades Arvinas to Hold From Buy, Cuts Price Target to $11 From $21 - marketscreener.com
Arvinas (ARVN) Downgraded by Truist Amid Market Concerns | ARVN Stock News - GuruFocus
Arvinas stock rating cut, price target slashed to $11 at Truist - Investing.com Australia
Arvinas: Yet Another Biotech Trading Below Net Cash, But It's Only A Mild Bull Case - Seeking Alpha
Piper Sandler Reiterates Overweight Rating for Arvinas (NASDAQ:ARVN) - MarketBeat
Arvinas (NASDAQ:ARVN) Price Target Cut to $16.00 by Analysts at Barclays - MarketBeat
HC Wainwright Cuts Arvinas (NASDAQ:ARVN) Price Target to $24.00 - MarketBeat
Arvinas (NASDAQ:ARVN) Lowered to Hold Rating by TD Cowen - MarketBeat
Arvinas, Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates - Yahoo Finance
Jefferies Financial Group Reaffirms "Hold" Rating for Arvinas (NASDAQ:ARVN) - MarketBeat
Boxer Capital Management LLC Makes New Investment in Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat
Arvinas, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud AllegationsARVN - ACCESS Newswire
Arvinas, Inc. (NASDAQ:ARVN) Shares Bought by Barclays PLC - MarketBeat
Arvinas (ARVN) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Price T Rowe Associates Inc. MD Has $78.66 Million Stock Holdings in Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat
Schonfeld Strategic Advisors LLC Has $12.58 Million Stock Holdings in Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat
Renaissance Technologies LLC Lowers Stock Position in Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat
Brokerages Set Arvinas, Inc. (NASDAQ:ARVN) Price Target at $34.33 - MarketBeat
Arvinas, Inc. (ARVN) Shareholders May Have Been Affected by FraudLevi & Korsinsky Investigates - ACCESS Newswire
Arvinas stock rating cut to hold at TD Cowen after trial cancellations - Investing.com India
Arvinas Earnings Call: Clinical Progress and Strategic Shifts - TipRanks
BTIG cuts Arvinas stock price target to $16 from $69 By Investing.com - Investing.com South Africa
Levi & Korsinsky Announces an Investigation on Behalf of Arvinas, Inc. (ARVN) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
Arvinas (ARVN) Stock: Wells Fargo Lowers Price Target to $19 | ARVN Stock News - GuruFocus
Arvinas (ARVN) Faces Price Target Cut Amid Strategic Adjustments | ARVN Stock News - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
Arvinas price target lowered to $10 from $20 at BMO Capital - TipRanks
Arvinas (ARVN) Target Price Lowered by Goldman Sachs | ARVN Stock News - GuruFocus
Guggenheim Maintains Buy Rating but Lowers Price Target for ARVN | ARVN Stock News - GuruFocus
Arvinas price target lowered to $14 from $24 at Piper Sandler - TipRanks
Arvinas price target lowered to $16 from $69 at BTIG - TipRanks
Arvinas (ARVN): Piper Sandler Adjusts Price Target Amid Reiteration of Rating | ARVN Stock News - GuruFocus
Barclays Analyst Lowers Price Target for Arvinas (ARVN) by 50% | ARVN Stock News - GuruFocus
Arvinas (ARVN) Price Target Reduced Following Strategic Restruct - GuruFocus
Arvinas Holding Company: Buy Rating Affirmed Amidst Promising Vepdeg Potential and Strong Financial Position - TipRanks
ARVN: HC Wainwright & Co. Adjusts Price Target While Maintaining Buy Rating | ARVN Stock News - GuruFocus
Here are 1 Main Capital Partners’ Views on Arvinas (ARVN) - Insider Monkey
Arvinas (ARVN) Price Target Reduced Following Strategic Restructuring | ARVN Stock News - GuruFocus
Jefferies Downgrades Arvinas (ARVN) with Significant Price Targe - GuruFocus
Arvinas (ARVN) Experiences Price Target Reduction Amid Developme - GuruFocus
Arvinas price target lowered to $16 from $32 at Guggenheim - TipRanks
Arvinas (ARVN) Experiences Price Target Reduction Amid Development Shift | ARVN Stock News - GuruFocus
Jefferies Downgrades Arvinas (ARVN) with Significant Price Target Cut | ARVN Stock News - GuruFocus
Arvinas Inc (ARVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.27%
0.30%
자본화:
|
볼륨(24시간):